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Objective: We sought to evaluate possible predictors of early and late pacemaker
infections in children.
Methods: A review was performed of all pacemakers implanted in children at The
Children’s Hospital of Philadelphia between 1982 and 2001. Infections were clas-
sified as superficial cellulitus, deep pacemaker pocket infection necessitating re-
moval, or positive blood culture without an identifiable source.
Results: A total of 385 pacemakers (224 epicardial and 161 endocardial) were
implanted in 267 patients at 8.4  6.2 years. All 2141 outpatient visits were
reviewed (median follow-up, 29.4 months; range, 2-232 months). There were 30
(7.8%) pacemaker infections: 19 (4.9%) superficial infections; 9 (2.3%) pocket
infections; and 2 (0.5%) isolated positive blood cultures. All superficial infec-
tions resolved with intravenous antibiotics. The median time from implantation
to infection was 16 days (range, 2 days-5 years). Only 1 deep infection occurred
after primary pacemaker implantation. Six patients with deep infections were
pacemaker dependent and were successfully managed with intravenous antibi-
otics, followed by lead-generator removal and implantation of a new pacemaker
in a remote location. In univariate analyses trisomy 21 (relative risk, 3.9; P 
.01), pacemaker revisions (relative risk, 2.5; P  .01), and single-chamber
devices (relative risk, 2.4; P  .05) were identified as predictors of infection.
However, in multivariate analyses only trisomy 21 and pacemaker revisions
were predictors.
Conclusions: The incidences of superficial and deep pacemaker infections were
4.9% and 2.3%, respectively. Trisomy 21 and pacemaker revisions were significant
risk factors in the development of infection after pacemaker implantation. For
primary pacemaker implantation, the risk of infection requiring system removal is
low (0.3%).
Permanent pacemaker technology and pacing techniques in childrenhave advanced considerably in the last few decades, with a current5-year lead survival of 75% to 85%.1,2 Despite advances in leadtechnology and current programmable generator features, compli-cations remain a serious and potentially life-threatening problem ofboth epicardial and endocardial systems. Deep pacemaker pocket
infections have been reported in 1% to 2% of adult patients and often require
removal of the infected generator and lead or leads.3-5 However, little informa-
tion currently exists concerning early and late pacemaker-related infections in
children. This study was undertaken to assess the incidence and possible
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predictors of pediatric pacemaker infections in a large
single-center cohort over 2 decades.
Methods
The cardiac surgical and pacemaker databases were reviewed to
identify patients who underwent permanent pacemaker implanta-
tion between July 1, 1982, and June 30, 2001, at The Children’s
Hospital of Philadelphia. Patients older than 21 years at the time of
pacemaker implantation were excluded. All hospital and operative
records, as well as the 2141 outpatient pacemaker clinic visits,
were retrospectively reviewed. These records were abstracted for
potential predictors of pacemaker infections (Table 1).
Operative Techniques
Epicardial leads were implanted by using standard surgical tech-
niques either through a midline sternotomy, lateral thoracotomy, or
subxiphoid approach. The surgical approach was based on the
patient’s underlying cardiac anatomy, morphologic cardiac posi-
tion in situ, previous operations, and/or concurrent operation at the
time of lead placement. The ventricular lead was often fixed on the
diaphragmatic ventricular surface. The atrial lead was positioned
on either the right or left atrium. The surplus of lead was addressed
by creating loops of the electrode within the pericardium and the
pacemaker pocket. Leads were tunneled with care to avoid sites of
potential injury along the rib margins to the generator implant site
in the abdomen.
Endocardial leads were implanted through percutaneous punc-
ture of the right or left subclavian vein. In rare instances cutdown
of either the subclavian or cephalic vein was performed. By using
a standard Seldinger technique, a guide wire was advanced, and a
sheath was secured over the guide wire and the pacing lead or
leads positioned in the atrium, ventricle, or both. The generator
was placed in either a subcutaneous or subpectoral position. Intra-
venous antibiotics, typically cefazolin, were given intraoperatively
and then for 24 to 48 hours after pacemaker implantation.
Hospital Course and Follow-up
Hospital charts were reviewed for length of stay, complications,
number and duration of antibiotics received, and discharge pacing
characteristics. Records were also reviewed for all isolated gener-
ator changes without lead revisions and subsequent complications.
Outpatient pacemaker follow-up generally occurred 1 and 3
months after implantation and then biannually. Perioperative in-
fections were defined as occurring before discharge after the initial
pacemaker implantation. Early complications were defined as any
infection requiring readmission or additional diagnostic examina-
tions (blood culture and wound aspiration) during the first 60 days
after pacemaker implantation. Readmission for bacteremia, skin
erosion, or pacemaker infection beyond 60 days was considered a
late complication. Pacemaker infections were based on modifica-
tions to criteria by Choo and associates6 and included the follow-
ing: (1) superficial infection (with or without a positive blood
culture); (2) deep infection necessitating generator-lead removal;
or (3) fever associated with positive blood culture without a focus
of infection elsewhere. All records at readmission were reviewed
with specific attention to duration and type of intravenous and oral
antibiotics used, wound and blood culture results, and need for
removal of the generator, extraction of the lead or leads, or both.
Statistical Analysis
Exploratory data analysis was performed by using descriptive
measures. Categoric variables were expressed as percentages with
associated SDs. Continuous variables were expressed as means
with SDs if the term was normally distributed, and skewed vari-
ables were expressed as medians with ranges. The strength of
statistical associations between categoric factors was assessed by
using 2 tests for categoric variables. When the expected cell
numbers were small, the Fisher exact test was used. Statistical
significance of the difference between continuous variables was
assessed with the Wilcoxon rank sum test for skewed distribution.
Logistic regression modeling was used to assess potential con-
founding variables with STATA 6.0 software (College Station,
Tex).
Results
Patient Data
A total of 267 patients (113 female and 154 male patients)
underwent 385 pacemaker implantations during the 20-year
study period. Of these 267 patients, 172 (64%) continued to
use their primary pacemaker system throughout the study
period without either a lead change, generator change, or
both. Within the total cohort, 59 (22%) patients underwent
a combination of 76 reoperations for generator and lead
replacement. Of the 267 patients, 36 underwent 42 (9%)
elective isolated generator changes. The median age at
primary pacemaker implantation was 7.3 years (3 months
of age, n  36; 3 months-1 year, n  13; 1-5 years, n  61;
5-10 years, n  56; and 10 years, n  101). The median
weight at lead implantation was 24.9 kg (range, 1.4-156 kg).
Indications for pacemaker placement included postoperative
atrioventricular block in 83 (31%) patients, sinus node dys-
function in 90 (34%) patients, congenital complete heart
block in 54 (20%) patients, bradycardia associated with long
QT syndrome in 14 (5.3%) patients, and other indications,
such as bradycardia caused by antiarrhythmic medication,
ventricular tachycardia, or antitachycardia pacemakers in 26
(9.7%) patients.
The majority of our patients (70%) had structurally ab-
normal hearts and had undergone surgical correction of
TABLE 1. Variables entered into univariate analyses
Age at implantation
Weight at implantation
Cardiac malformation
Era of implantation (1980-85, 1985-1990, 1990-1995, 1995-2001)
Trisomy 21
Cardiac surgical procedures (type and number)
Surgical approach (transvenous vs epicardial)
Concurrent cardiac procedure
Indication for pacing
Chamber paced
Single- vs dual-chamber pacemaker
Lead fixation
Initial implantation vs pacemaker revision
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complex cardiac malformations (Table 2). Of the 187 pa-
tients with congenital heart disease, 62 (33%) had some
form of single-ventricle physiology. Trisomy 21 was
present in 23 (8.6%) patients. Follow-up was complete to
June 30, 2001, in 91.9% of patients for a median of 29.4
months (range, 2-232 months).
Pacing Characteristics
The initial pacing mode (excluding generator changes) used
was atrial in 26 patients, ventricular without atrial synchro-
nization in 154 patients, atrioventricular in a synchronized
mode in 130 patients, and atrial sensed and ventricular
paced in 17 patients. Sixteen patients underwent implanta-
tion of an automatic internal cardioverter defibrillator.
Operative and Perioperative Course
Epicardial pacing systems accounted for 58% (n  224) of
generators used, and endocardial systems contributed to the
remaining 42% (n  161). Epicardial leads were implanted
through a subxiphoid approach (26 [13%]), lateral thoracot-
omy (41 [21%]), or a sternotomy (129 [66%]). Endocardial
leads were implanted through a left (111 [75.5%]) or right
(32 [22%]) subclavian venipuncture, cephalic cutdown (3
[2%]), or internal jugular approach (1 [0.5%]). A temporary
pacing lead was present at the time of permanent pacemaker
implantation in 55 of the 343 lead and generator implants
(16%; epicardial, 45/196; endocardial, 10/147). For the 147
primary endocardial implants, the pacemaker pocket was
subpectoral in 82 (56%) systems. In the remaining 65 (44%)
implants, the generator was subcutaneously positioned.
Implantation of the pacemaker occurred concurrently
with a cardiac procedure in 37 (9.6%) patients, typically
after cardiopulmonary bypass. In 92 (24%) patients implan-
tation of the generator occurred within 14 days of cardiac
surgery, most typically as a result of postoperative atrioven-
tricular block. The remainder of the pacemaker (n  256
[66.4%]) implantations occurred at a time remote from
either reparative or palliative cardiac surgery. Chest tubes
were implanted in 108 patients for an average of 1 day
(range, 0-27 days). Antibiotics (cefazolin, vancomycin, or
both) were given to all patients intraoperatively and then for
an additional 24 to 48 hours in 98% of the cohort. Prophy-
lactic antibiotics were not routinely used postoperatively
before 1988. The median length of stay after an isolated
pacemaker implantation was 3 days (range, 1-122 days).
Perioperative Infections (Before Hospital Discharge)
Five (1.2%) patients has a superficial skin infection before
hospital discharge after the initial pacemaker implantation.
The median time from implantation to the development of
superficial cellulitus was 7 days (range, 2-15 days). In one
patient Staphylococcus epidermidis grew from the wound
aspirate. In the remaining 4 patients, the wound cultures
revealed no growth. None of these 5 patients had a positive
blood culture. All 5 patients were successfully treated with
an additional 7-day course of intravenous antibiotics (1
cefazolin, 2 vancomycin, and 1 oxacillin). None of these 5
patients were readmitted at a later date with a recrudescent
pacemaker infection.
One (0.2%) deep-pocket infection occurred 14 days after
implantation of an epicardial atrial pacing lead at the time of
resection of fibrous subaortic stenosis in a patient after
Fontan surgery. Wound cultures revealed Pseudomonas
aeruginosa and a coagulase-positive Staphylococcus spe-
cies. This patient received 2 weeks of intravenous vanco-
mycin, tobramycin, and ciprofloxacin and was eventually
discharged home with oral ciprofloxacin for a period of 3
months. However, within 55 days, the patient was readmit-
ted, with erythema and swelling over the generator site. The
patient was started on intravenous tobramycin and ticarcillin
and within 72 hours underwent division of the lead with
generator removal and placement of a new epicardial ven-
tricular pacemaker through a left lateral thoracotomy. The
generator was tunneled to a remote preperitoneal abdominal
location. The wound culture from the old generator site
grew P aeruginosa, for which the patient received 3 months
TABLE 2. Anatomic features of patients receiving pace-
makers (n  267)
Structurally normal heart 80
Single-ventricle heart disease 62
Tricuspid atresia, NRGA 7
Tricuspid atresia, TGA 19
Hypoplastic left heart syndrome 18
Single RV 9
Heterotaxy 5
Other 4
Complete common AV canal 24
TGA (S,D,D) 18
Ventriculoseptal defect 15
Tetralogy of Fallot 12
Complex LVOTO 11
TGA (S,L,L) (VSD) 9
Double-outlet right ventricle 5
Primum ASD 5
Secundum ASD 5
Heterotaxy syndrome and AV canal 4
Partial anomalous pulmonary venous return 4
Hypertrophic cardiomyopathy 2
Patent ductus arteriosus 2
Mitral valve replacement 2
Truncus arteriosus 1
Pulmonary stenosis 1
Dilated cardiomyopathy 1
Anomalous left coronary artery 1
S/P orthotopic heart transplant 1
Ebstein anomaly 1
NRGA, Normally related great arteries; TGA, transposition of the great
arteries; RV, right ventricle; AV, atrioventricular; LVOTO, left ventricular
outflow tract obstruction; VSD, ventricular septal defect; ASD, atrial septal
defect; S/P, status post.
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of intravenous antibiotics and an additional 6 months of oral
ciprofloxacin. The old abdominal generator site was irri-
gated, packed daily, and closed by secondary intent. No
complications ensued from the subsequently placed ventric-
ular generator. However, the patient returned 10 months
later with erythema around the original pacemaker pocket.
A computed tomographic scan revealed fluid collection
around the previously transected ventricular lead. An inci-
sion extending into the subxiphoid region identified the old
epicardial lead, which was completely removed from the
diaphragmatic surface of the right ventricle. The patient
recovered without further complications.
Early Pacemaker Infections (<60 Days After
Implantation)
Twelve (3.1%) patients had a superficial wound infection
within 60 days of pacemaker implantation (18 days; range,
2-37 days). Of these 12 patients, 11 occurred after implan-
tation of a primary pacing system, whereas one superficial
infection occurred solely after an elective generator change.
In all 12 patients, a peripheral blood culture before initiation
of antibiotics revealed no organism. A wound aspirate from
one individual grew Staphylococcus aureus, and all other
wound cultures were negative. Patients were managed with
intravenous cefazolin for 2 to 7 days and then with an
additional 7 to 14 days of oral cephalexin on an outpatient
basis. No patient required removal of the lead, generator, or
both. No patient required readmission for a worsening in-
fection requiring additional antibiotics. In all 12 patients, a
follow-up outpatient visit 2 weeks after discharge revealed
resolution of the superficial erythema.
An early deep pacemaker pocket infection was observed in
5 (1.2%) patients (implant: median age, 4.1 years; range, 2
weeks-10 years; weight at implant: 16.3 kg; range, 3-28 kg)
(Table 3). Of these 5 patients, 2 had a deep-pocket infection
after a lead revision and generator change, and 2 others oc-
curred after an elective generator change. The median time
from pacemaker implantation to deep-pocket infection was 16
days (range, 8-47 days). All 5 patients had complex congenital
heart disease, and 3 had single-ventricle physiology. In 4 of the
5 patients, the pacemaker revision occurred without an asso-
TABLE 3. Clinical and bacteriologic data from the 9 deep pacemaker infections
Case
no.
Age/
sex
Primary
implant E/T CHD
Type
of
pacer
Time (days)
implant to
infection Etiology Treatment Outcome
Recurrent
infection
1 14/F No E Single ventricle,
Fontan
VVI 12 Pseudomonas
aeruginosa
Tobramycin and
ticarcillin
1 mo;
ciprofloxacin
3 mo
Partial lead/generator
removed; changed to
remote site
Yes
2 .2/M Yes E HLHS/Norwood AAI 8 Serratia Gentamicin and
ceftriaxone
Died (low cardiac output
after Norwood)
No
3 4/M No E Tetralogy of
Fallot
VVI 16* 0 Ceftriaxone 14 d Lead/generator removed
(adequate escape)
No
4 6/F No E Single ventricle,
Fontan
VVI 34 Pseudomonas
aeruginosa
Vancomycin and
netilmicin 14 d
Lead/generator removed;
changed to remote
site
No
5 10/M No T Trisomy 21, AV
canal
VVI 14* Staph species
(broth only)
Ceftriaxone 14 d Pocket aspirated;
resolved with
antibiotics
No
6 .7/M No E Single ventricle,
Glenn
DDD 35 Klebsiella Vancomycin 14
d; cephalexin
14 d
Lead/generator removed;
changed to remote site
No
7 17/M No T None DDD 176 Staph species
(broth only)
Vancomycin and
ancef 5 d;
Aug 14 d
Lead/generator removed;
changed to epicardial
No
8 10/F No E Trisomy 21, AV
canal
VVI 301 Staph aureus Vancomycin and
gentamicin
10 d;
ciprofloxacin
14 d
Partial lead/generator
removed; changed to
remote site
Yes
9 11/M No E Aortic stenosis VVI 1736 0 Vancomycin 7 d;
aug 14 d
Lead/generator removed;
changed to remote site
No
E, Epicardial; T, transvenous; HLHS, hypoplastic left heart syndrome; AV, atrioventricular.
*Generator change only.
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ciated nonpacemaker cardiac procedure. In one patient with
hypoplastic left heart syndrome, the primary pacing system
was implanted 3 weeks after a stage I Norwood procedure for
sinus bradycardia and low cardiac output. This patient even-
tually had Serratia marcesans septicemia and required re-
moval of the generator; the patient died 3 weeks later.
In the remaining 4 patients with an early deep-pocket
infection, microbiologic studies revealed no organism in
one patient, Klebsiella species (wound and blood) in one
patient, P aeruginosa (wound) in one patient, and an un-
identified Staphylococcus species (blood) in one patient. All
4 patients had removal of the generator, and 3 also under-
went lead extraction. A new pacemaker system was im-
planted in 2 patients after a brief period of intravenous
antibiotics (7-10 days) at a remote site. One patient with
trisomy 21 and complete heart block after atrioventricular
canal repair underwent exteriorization of the generator, 2
weeks of intravenous ceftriaxone, and daily dressing
changes. A new generator connected to the original epicardial
leads was successfully implanted without reinfection. One
patient with complete heart block after repair of tetralogy of
Fallot had been recently given a diagnosis of stage IV neuro-
blastoma and underwent an elective generator change for end-
of-life battery indices. The patient had a deep-pocket infection
during a period of severe neutropenia while receiving chemo-
therapy. As a result of having an adequate escape rhythm
(ventricular rate, 70 beats/min), the family and physicians
elected to refrain from pacemaker reimplantation until the
patient recovered from neuroblastoma.
One 2-month-old patient with third-degree atrioventric-
ular block after repair of a ventricular septal defect had
isolated Enterococcus bacteremia and received 42 days of
ampicillin and gentamicin. The patient recovered without
incident and did not require the generator, lead, or both to be
removed.
Late Pacemaker Infections (>60 Days After
Implantation)
A late superficial pacemaker infection was identified in 2
(0.5%) patients (aged 2 and 11 years) 136 and 211 days,
respectively, after an isolated implantation of a single-
chamber ventricular epicardial pacing system. Blood cul-
tures were negative in both patients, and each responded to
a brief (5 days) course of intravenous antibiotics and an
additional 7 days of oral antibiotics. Neither late superficial
infection progressed to a deep-pocket infection necessitat-
ing pacemaker removal.
Two pacemaker-dependent patients with epicardial leads
and one patient with an endocardial system had a late
deep-pocket infection necessitating pacemaker removal. A
gram-positive species was identified in the wound aspirate
of 2 patients; however, both had negative blood cultures.
One of these patients, a 10-year-old girl with trisomy 21,
sustained an epicardial lead fracture and underwent place-
ment of a new epicardial ventricular pacing system. The
patient did well initially and 9 months later underwent
abdominal exploration for a possible ventral hernia, which
revealed infection at the previous fractured pacing lead. The
generator was removed, and the fractured epicardial lead
was cut and allowed to retract. Despite 1 week of intrave-
nous antibiotics, the patient presented with a purulent sub-
xiphoid fluid collection (S aureus) requiring reopening of
the lower portion of the sternum and removal of the previ-
ously cut epicardial lead. A new transvenous system was
placed with a subpectoral pocket. In all 3 pacemaker-
dependent patients, 2 to 5 days of intravenous antibiotics
preceded generator and total lead extraction, with concom-
itant implantation of a new pacing system in a remote
location. An additional 10 to 14 days of intravenous anti-
biotics were given, followed by 1 week of oral antibiotics.
No additional late complications or deaths occurred among
any of the patients with a superficial or deep-pocket infec-
tion. S epidermidis bacteremia without an identifiable
source was observed in a 13-year-old patient with tetralogy
of Fallot 3.5 years after implantation of a dual-chamber
epicardial pacemaker. The patient was treated with vanco-
mycin and netilmicin for 6 weeks, with resolution of the
bacteremia. No subsequent pacemaker infection ensued.
Predictors of Pacemaker Infections
The 1- and 2-year freedoms from pacemaker (superficial
and deep) infection were 97% and 93%, respectively (Fig-
ure 1). No significant difference was observed in the inci-
dence of superficial infections on the basis of a primary
implantation. However, of the 9 deep infections, 8 were a
Figure 1. Freedom from pacemaker infection. Dashed lines denote
95% confidence limits about the point estimates. Numbers in
parentheses denote number of patients at that time point for
whom follow-up data were available. The 1-, 2-, 5-, and 10-year
percentages of freedom from pacemaker infection (with confi-
dence limits) are 96.8 (93.9-98.3), 92.9 (88.9-95.5), 86.5 (80.7-90.7),
and 86.5 (80.7-90.7). Three individuals had pacemaker infections
after 10 years.
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revision of a previous lead, generator, or both. Only one patient
had a deep-pocket infection after a primary pacemaker implan-
tation, although this patient had undergone palliative cardiac
surgery 3 weeks earlier. In total, those undergoing a second or
subsequent pacemaker replacement were 2.5 times as likely to
have a pacemaker infection compared with those undergoing a
primary implantation (14.0% vs 5.6%; relative risk [RR], 2.5;
P  .01). No additional risk of infection was observed on the
basis of the era of implant in either the univariate (P .29) or
multivariate analyses.
Of the 31 generators implanted in the 23 patients with
trisomy 21, 7 (22.6%) patients had a superficial cellulitus,
and 2 (6.4%) had a deep-pocket infection requiring pace-
maker removal. Patients with trisomy 21 were thus nearly 4
times as likely to have a pacemaker infection compared with
the remainder of the cohort (25.8% vs 6.5%; RR, 3.9; P 
.01). In univariate analyses single-chamber pacemakers had
a higher incidence of infection than dual-chamber systems
(single chamber: 10.2% vs dual chamber: 4.3%; RR, 0.4; P
.05). However, this association is confounded by the high rate
of single-chamber pacer use among patients with Down syn-
drome, who were more likely to experience pacer infections.
Age or weight at implantation, presence of congenital heart
disease, implantation during a concomitant cardiac procedure,
or era of implantation did not predict the development of a
superficial or deep pacemaker infection. Although no differ-
ence in the incidence of superficial infections was identified
with the position of the pacemaker pocket, all 9 deep-pocket
infections occurred with a subcutaneous or preperitoneal
pocket (P  .01). No deep pacemaker infection occurred in
this series when a subpectoral pocket was used. Use of tem-
porary epicardial or endocardial wires before permanent pace-
maker implantation did not alter the risk of infection. The use
of perioperative antibiotics could not be assessed as a prophy-
lactic measure in the prevention of pacemaker infections be-
cause greater than 90% of the cohort received antibiotics for at
least 24 hours after the operation.
Discussion
Permanent pacemakers have had a considerable effect in the
management of children with atrioventricular block, symp-
tomatic sinus node dysfunction, and, recently, as an adjunct
in the therapy of tachyarrhythmias.1,2,7-10 Although ad-
vances in technology and improving expertise in lead im-
plantation have made pacemaker implantation relatively
simple and safe, caution must be exercised when implanta-
tion of a foreign body occurs.
Because most of the experience with pediatric pace-
maker infections results from anecdotal cases, we sought to
report the incidence, possible predictors, and management
strategies involving pacemaker infections in children over
the last 20 years. Furthermore, because most of the adult
experience involves transvenous leads, little information
has been reported with epicardial pacemaker infections.
Early infections after pacemaker implantation are
thought to result from wound contamination at the opera-
tion.5 Most of these infections appear to manifest within the
first 2 months after the operation and are isolated within the
generator pocket.3,5 On the basis of criteria by Choo and
associates,6 we identified an early incidence of superficial
infection of 4.4% (n 17) and deep-pocket infection of 1.5%
(n  6). Although the incidence of deep-pocket infections in
our study is similar to incidences seen in large adult cohorts
(0.7%-1.0%), our incidence of superficial infections is greater
than the 0.8% reported in adult studies.3,4 However, in both our
pediatric population and the comparative adult studies, all
superficial infections were treated successfully with antibiotics
and did not require additional operations.
Surgical infections occur when the combination of mi-
crobial numbers and virulence is sufficiently large enough
to overcome the local host defense mechanisms. Wound
infections tend to be more common in the young11 and
might relate to immature resistance mechanisms. Although
strict adherence to sterile surgical technique has dramati-
cally reduced the incidence of surgical infections, there
continue to be wound infections partly related to breaks in
technique but also caused by reduced host resistance. In our
study, patients with Down syndrome were 4 times as likely
to have a pacemaker infection than the remainder of the
cohort. Abnormalities in humoral and cell-mediated immu-
nity have been described in patients with Down syndrome
with reduced levels of immunoglobulin M, zinc, total lym-
phocyte counts, T and B lymphocytes, and T helper and
suppressor cells.12 In a prospective study Licastro and col-
leagues13 found that 4 months of oral zinc supplementation in
patients with Down syndrome resulted in normalization of
thymulin, increased lymphocyte proliferation and polymorpho-
nuclear activity, with a significantly reduced incidence of in-
fections. Alternatively, prophylactic use of vancomycin in
high-risk patients (ie, patients with Down syndrome) might
reduce the incidence of superficial infections.
The time interval between pacemaker implantation and
infectious symptoms is often quite variable. Although su-
perficial pocket infections tend to occur early in the adult
experience, deep-pocket infections involving the electrode
tend to occur later (median, 7-8 months).14 S aureus and
epidermidis appear to be the most consistent organisms
identified from adults with pacemaker-mediated infections.
Staphylococcus species was identified in 44% of the deep
pacemaker infections in our cohort.
Appropriate management of pacemaker-related infection
involves the complete removal of the generator and leads,
regardless of the extent and location of the infection. Delay or
failure to remove the entire pacemaker apparatus (leads and
generator) with a deep-pocket infection has been reported to
result in a mortality of 25% to 66% in adult studies.15,16
Conservative therapy with systemic antibiotics as the mainstay
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of therapy without removal of foreign material has also been
reported to fail in 97% of patients.6 The 2 patients in our cohort
who underwent partial lead extraction had a recurrent infection
necessitating a further operation to remove the remaining lead.
Our current approach and recommendations for deep pace-
maker infections involves intravenous antibiotics, removal of
all foreign material, and reimplantation at a remote site during
a single operation. The current availability of laser lead extrac-
tion might aid in the removal of all infected transvenous
hardware.
Use of a temporary pacing wire and repeat operations for
noninfected complications (principally lead revision) have
been identified as risk factors in pacemaker-mediated infec-
tions.4,17,18 Although temporary pacing leads were only used
in 6.8% of endocardial leads and 21% of epicardial leads, no
increased risk could be identified in our patient population.
It has been suggested that the adults who require temporary
transvenous pacing are generally sicker and have been iden-
tified preoperatively as being at high risk (ie, with diabetes
mellitus, leukemia, malnutrition, or long-term steroid
use).17 However, similar to the adult studies, of the 9 pa-
tients who had a deep-pocket infection in our cohort, all but
one occurred as a revision of a prior pacing system. These
indications include a lead change for fracture, poor pacing-
sensing, or an isolated generator change. Although it seems
logical that reopening the wound might predispose to infec-
tion, the exact pathophysiologic mechanism is less well
understood. The pacemaker pocket in a reoperated system
might be less well vascularized and have a decrease in tissue
oxygen tension, resulting in an increased susceptibility to
bacterial contamination, despite prophylactic antibiotics. In
addition, although pediatric pacemaker implantation has
evolved from a predominantly epicardial to endocardial
approach, one of the potential problems is the very thin
subcutaneous tissue, which often leaves the child with an
unpleasant cosmetic result and renders the incision more
susceptible to erosion and infection. Our approach over the
last 5 years has been to place all endocardial pacemakers
under the pectoralis major muscle. The absence of a deep-
pocket infection in any of the 82 pacemakers placed through
a subpectoral incision is consistent with earlier results by
Gillette and coworkers,19 who found the subpectoral pocket
to be the preferred site.
This study is limited by its retrospective data collection.
Furthermore, it is unknown to what extent antibiotics pre-
vented any of the superficial infections from progressing to
a deep-pocket infection.
In conclusion, superficial and pacemaker deep-pocket
infections occur less than 5% of the time, with Down
syndrome and reoperations accounting for the majority of
infections. Primary pacemaker implantation carries an ex-
ceedingly low risk of deep-pocket infection. As evidenced
by this study, the management of any deep-pocket infection
should include removal of the generator and leads in their
entirety. In the 2 instances of deep pacemaker infection
whereby only partial transection of the epicardial leads was
performed, both patients returned with a recurrent infection.
Further prospective work identifying and treating high-risk
patients might result in a lower incidence of wound infec-
tions and a need for generator and lead extractions.
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